Cash and Cash Equivalents, at Carrying Value of RayzeBio, Inc. from 30 Sep 2022 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
RayzeBio, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 30 Sep 2022 to 30 Sep 2023.
  • RayzeBio, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2023 was $251,964,000, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

RayzeBio, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $251,964,000 +$36,379,000 +17% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q4 2022 $129,159,000 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $215,585,000 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.